This article proposes a new index that seeks to measure the national strength of the pharmaceutical intellectual property environment of a given country. This Pharmaceutical IP Index focuses on four countries: the US, the UK, Singapore and Israel.
|Number of pages||19|
|Journal||The Journal of World Intellectual Property|
|State||Published - 2006|